Fasikl, Inc.
PrivateLast Round
Series B
Sep 10, 2025
Total Funding Raised
$59.8M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Fasikl, Inc. is a neuro-AI company that develops cloud-connected, AI-powered neuromodulation technologies and therapeutics for movement disorders.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Biotechnology
Business Model
B2B2C
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Fasikl, Inc. Comparables
Compare Fasikl, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Encora Therapeutics | 87% | |
| Allevion Therapeutics | 85% | |
| Cala Health | 85% |
Fasikl, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 10, 2025 | ||||
| Series A Extension | Sep 10, 2024 | ||||
| Series A | Mar 3, 2023 | ||||
| Seed | Nov 1, 2021 |
Key People
Founding team and executive leadership
Fasikl, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| iSeed | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 122% MoM, reaching 4.1K.
- May 2, 2026
Flagship non-invasive neuromodulation solution for essential tremor is FDA-cleared.
Fasikl, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Fasikl, Inc.'s valuation, stock price, and market status.
Is Fasikl, Inc. a public or private company?
Fasikl, Inc. is a private company.
What is the current stock price of Fasikl, Inc.?
Fasikl, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Fasikl, Inc. worth (valuation)?
Valuation information for Fasikl, Inc. is not publicly available.
Can I buy Fasikl, Inc. stock?
Fasikl, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Fasikl, Inc.'s last funding round?
Fasikl, Inc.'s most recent funding round was Series B on September 10, 2025.
Who are the main investors in Fasikl, Inc.?
Key investors in Fasikl, Inc. include iSeed.
Will Fasikl, Inc. IPO soon?
No public IPO plans have been announced for Fasikl, Inc..
How can I track Fasikl, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Fasikl, Inc.'s secondary market activity and sign up for updates.